FOXP3 and myeloid sarcoma: Foxp3+ Tregs in the brains of MS patients largely release IL-10 and have upregulation of the IL-33 receptor ST2 (linked with significant Treg action), implying that the repressive role of Tregs is maintained in the inflamed brain [98].